(19)
(11) EP 2 440 569 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.03.2017 Bulletin 2017/09

(45) Mention of the grant of the patent:
24.08.2016 Bulletin 2016/34

(21) Application number: 10786455.5

(22) Date of filing: 07.06.2010
(51) International Patent Classification (IPC): 
C07K 7/06(2006.01)
A61P 3/04(2006.01)
 A61K 38/08(2006.01)
(86) International application number:
PCT/SE2010/050626
(87) International publication number:
WO 2010/144038 (16.12.2010 Gazette 2010/50)

(54)

MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES

MELANOCORTINREZEPTORSPEZIFISCHE PEPTIDE

PEPTIDES SPÉCIFIQUES DU RÉCEPTEUR DE MÉLANOCORTINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
BA ME RS

(30) Priority: 08.06.2009 US 184932 P

(43) Date of publication of application:
18.04.2012 Bulletin 2012/16

(73) Proprietor: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • DODD, John H.
    Cranbury, NJ 08512 (US)
  • SHI, Yi-Qun
    Cranbury, NJ 08512 (US)
  • YANG, Wei
    Cranbury, NJ 08512 (US)

(74) Representative: Hart, Deborah Mary et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)


(56) References cited: : 
WO-A1-2009/151383
WO-A2-03/006620
US-A1- 2004 138 136
 WO-A1-2009/152079
WO-A2-2005/030797
US-B2- 7 541 430
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).